跳至主要内容
临床试验/JPRN-UMIN000007371
JPRN-UMIN000007371已完成未知

Prospective evaluation of renal function and proteinuria in chronic kidney disease patients - Prospective evaluation of renal function and proteinuria in chronic kidney disease patients (PERFECT study)

Aichi welfare agricultural cooperative association Anjo Kosei Hospital0 个研究点目标入组 60 人开始时间: 2012年2月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patient who caused acute coronary syndrome within six months. The patient of an inflammatory disorder, infection, and a malignant tumor. The patient who has an anamnesis of hypersensitivity to atorvastatin and/or rosuvastatin. A pregnant woman or the woman that may have become pregnant, and a nursing mother. A patient with critical impaired liver function and renal dysfunction.

研究者

发起方
Aichi welfare agricultural cooperative association Anjo Kosei Hospital

相似试验

已完成
不适用
Prognostic evaluation with focus on renal function of molecular target drugs for Unresectable or Metastatic Renal Cell Carcinoma patients with Renal DysfunctioRenal cell carcinoma
JPRN-UMIN000021981Shinshu University school of medicine30
招募中
不适用
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosis
JPRN-UMIN000040179Hokkaido University400
已完成
不适用
Retrospective study to assess renal function using MAG3 renogram in patients with renal tumor who treated by carbon ion radiotherapyRenal tumor
JPRN-UMIN000039928ational Institute of Radiological Sciences (NIRS), QST20
已完成
不适用
rinary neutrophil gelatinase-associated lipocalin(NGAL) excretion and Renal Functions in Mild Maternal HydronephrosisMild Maternal Hydronephrosis in PregnancyRenal and Urogenital - Kidney diseaseReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
ACTRN12614000455662Emre Goksan Pabuccu86
进行中(未招募)
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851
EUCTR2014-005033-31-FRAddmedica S.A.S